Compare DexCom, Inc. (DXCM) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Riot Platforms Inc — how do they compare? DexCom, Inc. trades at $77.61 (market cap $28.06B), while Riot Platforms Inc trades at $18.62 (market cap $7.60B). The key difference: DexCom, Inc. is far larger — about 3.7× Riot Platforms Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Riot Platforms Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | RIOT | |
|---|---|---|
Market Cap | $28.06B | $7.60B |
Sector | Health | Technology |
52-Week High | $89.53 | $28.67 |
52-Week Low | $54.84 | $11.03 |
Enterprise Value | $27.03B | $8.27B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
RIOT trades at $18.89, down 6.44% over 24 hours, with a bearish technical signal from moving averages. The company reported a net loss of $663.18M in 2025 despite $647.44M revenue, reflecting negative profit margins. Recent earnings missed expectations in Q4 2025 and Q1 2026. Analyst consensus remains strongly bullish with a $27.86 price target, supported by 17 buy ratings. News highlights volatility amid Bitcoin price swings and Texas grid reliability concerns affecting data center operations.
Outlook is mixed: strong analyst support suggests upside potential, but persistent losses and operational cash flow deficits pose significant risks. Investors face exposure to cryptocurrency market volatility and execution challenges in expanding high-performance compute capacity. The stock's current price near support levels may attract buyers if fundamentals improve.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
